skip to main content
Idioma:

Resultados de 1 a 10 de 50  para Produção Intelectual da USP

Ordenado por: Ordenado por: RelevânciaOr hit Enter to replace sort method
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial
Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial

Pierre Theroux Paul W Armstrong; Lina M Gonzales; Kenneth W Mahaffey; Judith S Hochman; Scott Rollins; Kevin J Malloy; Thomas Parish; José Carlos Nicolau; Joel Lavoie; Christopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)

Journal American College of Cardiology New York v.43, suppl. A, p. 287A, res. 833-5, 2004

New York 2004

Localização: FM - Fac. Medicina    (BCSEP 2004 65 ) e outros locais(Acessar)

2
Cardiovascular clinical research in South America
Cardiovascular clinical research in South America
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cardiovascular clinical research in South America

José C. Nicolau Ramon Corbalan; Rafael Diaz; Cecilia Bahit; Paul W Armstrong; Christopher B Granger; Renato D Lopes

American Heart Journal St. Louis v. 165, n. 6, p. 848-853, 2013

St. Louis 2013

Localização: FM - Fac. Medicina    (BCSEP 291 2013 )(Acessar)

3
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Item não circula. Consulte sua biblioteca.(Acessar)

4
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial

Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau

Circulation, Baltimore v. 18, p. 1184-1190

Baltimore 2003

Item não circula. Consulte sua biblioteca.(Acessar)

5
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)

Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger

American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005

Orlando 2005

Localização: FM - Fac. Medicina    (FM BCBIB )(Acessar)

6
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial

Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau

Circulation, Baltimore v. 18, p. 1184-1190

Baltimore 2003

Item não circula. Consulte sua biblioteca.(Acessar)

7
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Item não circula. Consulte sua biblioteca.(Acessar)

8
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)

Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger

American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005

Orlando 2005

Localização: FM - Fac. Medicina    (FM BCBIB )(Acessar)

9
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes The TRACER Trial
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes The TRACER Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes The TRACER Trial

Pascal Vranckx Harvey D White; Zhen Huang; Kenneth W Mahaffey; Paul W Armstrong; Frans Van de Werf; David J Moliterno; Lars Wallentin; Claes Held; Philip E Aylward; Jan H Cornel; Christoph Bode; Kurt Huber; José C Nicolau; Witold Ruzyllo; Robert A Harrington; Pierluigi Tricoci

Journal of the American College of Cardiology New York v. 67, n. 18, p. 2135-2144, 2016

New York 2016

Acesso online. A biblioteca também possui exemplares impressos.

10
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Ralph A. H. Stewart Nermin Hadziosmanovic; Paul W Armstrong; Christopher P Cannon; Christopher B Granger; Emi Hagström; Judith S Hochman; Wolfgang Koenig; Eva Lonn; José C Nicolau; Philippe Gabriel Steg; Ola Vedin; Lars Wallentin; Harvey D White

Journal of the American College of Cardiology New York v. 70, n. 11, p. 1689-1700

New York 2017

Localização: FM - Fac. Medicina    (BCSEP 101/2017 )(Acessar)

Resultados de 1 a 10 de 50  para Produção Intelectual da USP

Ordenado por: Ordenado por: RelevânciaOr hit Enter to replace sort method
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Disponível na Biblioteca (39)
  2. Recursos Online (16)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (49)
  2. Livros  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2007  (11)
  2. 2007Até2010  (9)
  3. 2011Até2014  (10)
  4. 2015Até2019  (14)
  5. Após 2019  (6)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Armstrong, P
  2. Nicolau, J
  3. Ruzyllo, W
  4. Hochman, J
  5. White, H

Neste Assunto:

  1. Inflamação
  2. Mortalidade
  3. Infarto Do Miocárdio
  4. Fatores De Risco
  5. Doenças Cardiovasculares

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.